These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14619610)

  • 1. [Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
    Alekseeva RI; Meshcheriakova VA; Sharafetdinov KhKh; Plotnikova OA; Liutova LV; Karabasova MA; Andreenko GV
    Vopr Pitan; 2003; 72(5):18-21. PubMed ID: 14619610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
    Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the coagulation and fibrinolysis system in 54 patients with type 2 diabetes mellitus: correlations with lipid metabolism and blood glucose control].
    Moccia F; Colla G; Castelli F; Greco GM
    Clin Ter; 1996; 147(1-2):37-46. PubMed ID: 8767954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a monounsaturated fatty acids-enriched diet on the clinical and metabolic parameters in type 2 diabetic patients].
    Sharafetdinov KhKh; Plotnikova OA; Kulakova SN; Alekseeva RI; Meshcheriakova VA; Mal'tsev GIu
    Vopr Pitan; 2003; 72(4):20-4. PubMed ID: 12968299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Some parameters of hemostasis in diabetic patients].
    Sroczyński J; Krupa G; Chełmecka E; Galwas B; Matyszczyk B
    Pol Tyg Lek; 1989 May 1-8; 44(18-19):420-2. PubMed ID: 2700093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I; Masuda H
    Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D; Eriksson JW; Boman K; Svensson MK
    Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Food dietary supplement efficacy in complex therapy of patients with type 2 diabetes with obesity].
    Khrushcheva IuV; Mal'tsev GIu; Popova IuP; Vasil'ev AV
    Vopr Pitan; 2002; 71(2):27-31. PubMed ID: 12125471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of hypocaloric diet with supplemented biologically active substances with antioxidant activity on clinicometabolic parameters in type 2 diabetes mellitus patients].
    Sharafetdinov KhKh; Plotnikova OA; Zykina VV; Alekseeva RI; Mal'tsev GIu; Kaganov BS
    Vopr Pitan; 2009; 78(2):57-62. PubMed ID: 19514345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dietotherapy with enteral formulas on the dynamic of clinical and metabolic parameters in type 2 diabetic patients].
    Sharafetdinov KhKh; Plotnikova OA; Meshcheriakova VA
    Vopr Pitan; 2005; 74(2):26-32. PubMed ID: 15921201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of caloric restriction diet on clinical and biochemical parameters in patients with type 2 diabetes mellitus].
    Skripchenko ND; Sharafetdinov KhKh; Plotnikova OA; Meshcheriakova VA
    Vopr Pitan; 2002; 71(4):13-7. PubMed ID: 12462948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.